Bristol Myers, Cellares sign global CAR-T deal as biopharma companies look to
Bristol Myers, Cellares sign global CAR-T deal as biopharma companies look to diversify manufacturing partners Endpoints NewsBristol Myers signs $380 mln CAR-T therapies supply deal with Cellares ReutersWith $380M deal, Bristol Myers…